References
- Fed. Amer. Soc. Exp. Biol. v.31 Synthesis of a new antiinflammatory agent cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)-benzyl-idenyl]indene-3-acetic acid. Shen, T. Y.;Witzel, B. E.;JOnes, H.;Linn, B. O.;McPhreson, J.;Greenwald, R.;Fordice, M.;Jacobs, A.
- Drugs v.16 Sulindac-a review of its pharmacological properties and therapeutic efficiency in rheumatic diseases Brogden, R. N.;Heel, R. C.;Speight, T. M.;Avery, G. S.
- Martindale Analgesics and Antiinflammatory Agents Reynolds, J. E. F.
- Antiinflammatory Analgesics 4c v.8 no.3 MIMS Korea: Antirheumatic Cocabo, S. C.;Pharm, B. S.;Kin, P. T.
- Amer. Pharm Associ. v.13 Analytical profiles of drug substances-Sulindac Plakogiannis, F. M.;McCauley, J. A.
- Scand. J. Rheumatol. v.8(Suppl) Sulindac vs phenylbutazone in the treatment of ankylosing spondylitis Godamski, M.;Singer-Bakker, H.;Braun, H. D.
- Scand. J. Rheumatol. v.8(Suppl) Controlled clinical study comparing a new antiinflammatory agent sulindac (MK-231) with aspirin in the treatment of rheumatoid arthritis Highton, T. C.;Jeremy, R.
- Scand. J. Rheumatol. v.8(Suppl) Evaluation of sulindac (MK-231) in acute gout Worthington, W. W.
- Amer. J. Gastroenterol. v.82 no.11 Gastroduodenal mucos and dyspeptic symptons in arthritis patients during chronic nonsteroidal antiinflammatory drug use Larkai, E. N.;Smith, J. L.;Lidsky, M. D.;Graham, D. Y.
- Dig. Dis. Sci. v.28 no.2 Gastric bleeding and gastric secretion with sulindac and naproxen Hut, J. N.;Smith, J. L.;Jiang, C. L.
- Clin. Pharmacol. Ther. v.24 The disposition of sulindac in man Duggan, D. E.;Hare, L. E.;Ditzler, C. A.;Lei, B. w.;Kwan, K. C.
- Clin. Pharmacol Ther. v.33 no.2 Enterohepatic circulation of sulindac and metabolites Dujovne, C. A.;pitterman, A.;Vincek, W. C.;Dobrinska, M. R.;Davies, R. O.;Duggan, D. E.
- J. Pharmacol. Exp. Ther. v.201 Identification of the biologically active form of sulindac Duggan, D. E.;Hooke, K. F.;Risely, E. A.;Shen, T. Y.;Van Arman, C. G.
- Drug Meta. Dispos. v.1 Physiologic disposition and metabolic fate of a new antiinflammatory agent, cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylidenyl]indene-3-a-cetic acid in the rat, dog, rhesus monkey and man Huker, H. B.;Stauffer, S. C.;White, S. D.;Rhodes, R. A.;Arrison, B. H.;Umbenhauer, E. R.;Bower, R. J.;McMahon, F. G.
- Eur. J. Rheumatol. Inflam. Kwan, K. C.;Duggan, D. E.;Van Arman, C. G.;Shen, T. Y.
- Biochem. Pharmacol. v.25 Enterohephatic circulation of indomethacin and its role in intestinal irritation Duggan, D. E.;Hooke, K. F.;Noll, R. M.;Kwan, K. C.
- Scand. J. Rheumatol. v.4 multi-clinic double-blind study comparing sulindac (MK-231) to aspirin and ibuprofen in outpatients with osteroarthritis Ballabio, C. B.;Colombo, B. A.
- Sustained and Controlled Release Drug Delivery System v.1 An overview of prolonged action drug dosage forms Ballard, G.;J. R. Robinson(ed.)
- A. Pharm. Tech Pub. v.29 The controlled release oral drug delivery opportunity, drug delivery systems, proceedings of an international conference Courson, J. D.
- Drug and the phramaceutical sciences v.6 Sustained and Controlled Release Drug Delivery Systems Robinson, J. R.
- In oral sustained release formulations : design and evaluation v.1 Silber B. M.;Cheung, W. K.;Yccobi, A.;A. Yacobi(ed.);E. Halperin-Walgega(ed.)
- Drug Dev. Ind. Pharm. v.9 Oral controlled drug administration. Pharmacokinetic considerations Welling, P. G.
- YAKHAK HOEJI(in press) Dissolution properties of oral sustained release sulindac dilivery system Rhee, G. J.;Suh, S. S.;Whang, S. S.
- J. Pharm. Sci. v.66 Analysis of sulindac and metabolites by combined isotope dilution radioimmunoassay Hare, L. E.;Ditter, C. A.;Hickens, M.;Rosedgay, A.;duggan, D. E.
- Pharmacologist. v.16 Analysis of cis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)-benzylidenyl]indene-3-acetic acid and metabolites by combined isotope dilution radio immuno assay Hare, L. E.;Ditter, C. A.;Hickens, M.;Duggan, D. E.
- Anal. Biochem. v.95 Walker, R. W.;Gruber, V. F.;Rosenburg, A.;Wolf, F.;Avanden Heuvel, W.I.
- J. Chromatogr. v.416 no.2 Rapid high performance liquid chromatographic assay for the simultaneous analysis of nonsteroidal anti-inflammatory drugs in plasma Owen, S. G.;Roberts, M. S.;Friesen, W. T.
- J. Chromatogr. v.533 Liquid chromatography with amperometric detection for the determination of non-steroidal antiinflammatory drugs in plasma Kazemifard, A. G.;Moore, D. E.
- J. Pharm. Sci. v.73 Analytical methods for the determination of sulindac and mathabolites in plasma. urine, bile. and gastric fluid by liquid chromatography using ultraviolet detection Musson, D. G.;Vincek, W. C.;Constanzer, M. L.;Detty, T. E.
- J. Chromatogr. Sci. v.25 Liquid chromatographic determination of sulindac and metabolites in serum Clark, C. R.;McMillian, C. L.;Hoke, J. F.;Compagna, K. D.;Ravis, W. R.
- J. Chromatogr. v.20;414 no.1 High performance liquid chromatography of sulindac and its sulphone and sulfide methabolites in plasma Grgurinovich, N.
- J. Chromatogr. v.413 Analysis of sulindac and methabolites in plasma and urine by high performance liquid chromatography Stubbs, R. J.;Ng, L. L.;Entwistle, L. A.;Bayne, W. F.
- J. Chromatogr. v.257 no.2 Sample preparation by salts precipitation and quantitation by high performance liquid chromatography with UV detection of selected drugs in biological fluids Ng, L. L.
- Pharmacokinetics(2nd Ed.) Gibaldi, M.;Perrier, D.
- Biopharmaceutics and Clinical Pharmacokinetics(4th Ed.) Robert, E. N.
- Manual of pharmacologic calculations with computer programs(2nd Ed.) Tallarida, R. J.;Murray, B.